Skip to content
NewsBlazeAU – Lifestyle
Author:
Ipsen Pharma
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
May 16, 2026
Ipsen unveils corabotase, a first-in-class recombinant neuroinhibitor, RNI™, at the SCALE Symposium
May 14, 2026
←
Previous Page
1
2